PCR Technologies Market Size to Hit USD 31.39 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on PCR Technologies Market

5.1. COVID-19 Landscape: PCR Technologies Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global PCR Technologies Market, By Product Type

8.1. PCR Technologies Market Revenue and Volume, by Product Type

8.1.1. Instruments

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Reagents & Consumables

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Software & Services

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global PCR Technologies Market, By Technology Type

9.1. PCR Technologies Market Revenue and Volume, by Technology Type

9.1.1. Conventional PCR

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Real-Time PCR

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Digital PCR

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Multiplex PCR

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Reverse Transcription PCR (RT-PCR)

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Others (e.g., High-Fidelity PCR, Hot-Start PCR)

9.1.6.1. Market Revenue and Volume Forecast

Chapter 10. Global PCR Technologies Market, By Disease Area

10.1. PCR Technologies Market Revenue and Volume, by Disease Area

10.1.1. Neuromuscular Disorders (e.g., SMA)

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Ophthalmology (e.g., inherited retinal diseases)

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Hematologic Disorders (e.g., Hemophilia A/B)

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Metabolic Disorders (e.g., OTC deficiency, Fabry)

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Cardiovascular Disorders

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. CNS Disorders (e.g., MLD, Batten disease)

10.1.6.1. Market Revenue and Volume Forecast

10.1.7. Others (e.g., rare pediatric diseases)

10.1.7.1. Market Revenue and Volume Forecast

Chapter 11. Global PCR Technologies Market, By Application

11.1. PCR Technologies Market Revenue and Volume, by Application

11.1.1. Clinical Diagnostics

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Research & Academia

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Forensic Analysis

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Agriculture & Animal Testing

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Environmental Testing

11.1.5.1. Market Revenue and Volume Forecast

11.1.6. Others

11.1.6.1. Market Revenue and Volume Forecast

Chapter 12. Global PCR Technologies Market, By xEnd-User

12.1. PCR Technologies Market Revenue and Volume, by End-User

12.1.1. Hospitals & Diagnostic Laboratories

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Research Institutes & Universities

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Pharmaceutical & Biotechnology Companies

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Forensic Laboratories

12.1.4.1. Market Revenue and Volume Forecast

12.1.5. Agriculture & Food Testing Labs

12.1.5.1. Market Revenue and Volume Forecast

12.1.6. Others

12.1.6.1. Market Revenue and Volume Forecast

Chapter 13. Global PCR Technologies Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product Type

13.1.2. Market Revenue and Volume Forecast, by Technology Type

13.1.3. Market Revenue and Volume Forecast, by Disease Area

13.1.4. Market Revenue and Volume Forecast, by Application

13.1.5. Market Revenue and Volume Forecast, by End-User

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product Type

13.1.6.2. Market Revenue and Volume Forecast, by Technology Type

13.1.6.3. Market Revenue and Volume Forecast, by Disease Area

13.1.6.4. Market Revenue and Volume Forecast, by Application

13.1.6.5. Market Revenue and Volume Forecast, by End-User

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product Type

13.1.7.2. Market Revenue and Volume Forecast, by Technology Type

13.1.7.3. Market Revenue and Volume Forecast, by Disease Area

13.1.7.4. Market Revenue and Volume Forecast, by Application

13.1.7.5. Market Revenue and Volume Forecast, by End-User

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product Type

13.2.2. Market Revenue and Volume Forecast, by Technology Type

13.2.3. Market Revenue and Volume Forecast, by Disease Area

13.2.4. Market Revenue and Volume Forecast, by Application

13.2.5. Market Revenue and Volume Forecast, by End-User

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product Type

13.2.6.2. Market Revenue and Volume Forecast, by Technology Type

13.2.6.3. Market Revenue and Volume Forecast, by Disease Area

13.2.7. Market Revenue and Volume Forecast, by Application

13.2.8. Market Revenue and Volume Forecast, by End-User

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product Type

13.2.9.2. Market Revenue and Volume Forecast, by Technology Type

13.2.9.3. Market Revenue and Volume Forecast, by Disease Area

13.2.10. Market Revenue and Volume Forecast, by Application

13.2.11. Market Revenue and Volume Forecast, by End-User

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product Type

13.2.12.2. Market Revenue and Volume Forecast, by Technology Type

13.2.12.3. Market Revenue and Volume Forecast, by Disease Area

13.2.12.4. Market Revenue and Volume Forecast, by Application

13.2.13. Market Revenue and Volume Forecast, by End-User

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product Type

13.2.14.2. Market Revenue and Volume Forecast, by Technology Type

13.2.14.3. Market Revenue and Volume Forecast, by Disease Area

13.2.14.4. Market Revenue and Volume Forecast, by Application

13.2.15. Market Revenue and Volume Forecast, by End-User

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product Type

13.3.2. Market Revenue and Volume Forecast, by Technology Type

13.3.3. Market Revenue and Volume Forecast, by Disease Area

13.3.4. Market Revenue and Volume Forecast, by Application

13.3.5. Market Revenue and Volume Forecast, by End-User

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product Type

13.3.6.2. Market Revenue and Volume Forecast, by Technology Type

13.3.6.3. Market Revenue and Volume Forecast, by Disease Area

13.3.6.4. Market Revenue and Volume Forecast, by Application

13.3.7. Market Revenue and Volume Forecast, by End-User

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product Type

13.3.8.2. Market Revenue and Volume Forecast, by Technology Type

13.3.8.3. Market Revenue and Volume Forecast, by Disease Area

13.3.8.4. Market Revenue and Volume Forecast, by Application

13.3.9. Market Revenue and Volume Forecast, by End-User

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product Type

13.3.10.2. Market Revenue and Volume Forecast, by Technology Type

13.3.10.3. Market Revenue and Volume Forecast, by Disease Area

13.3.10.4. Market Revenue and Volume Forecast, by Application

13.3.10.5. Market Revenue and Volume Forecast, by End-User

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product Type

13.3.11.2. Market Revenue and Volume Forecast, by Technology Type

13.3.11.3. Market Revenue and Volume Forecast, by Disease Area

13.3.11.4. Market Revenue and Volume Forecast, by Application

13.3.11.5. Market Revenue and Volume Forecast, by End-User

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product Type

13.4.2. Market Revenue and Volume Forecast, by Technology Type

13.4.3. Market Revenue and Volume Forecast, by Disease Area

13.4.4. Market Revenue and Volume Forecast, by Application

13.4.5. Market Revenue and Volume Forecast, by End-User

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product Type

13.4.6.2. Market Revenue and Volume Forecast, by Technology Type

13.4.6.3. Market Revenue and Volume Forecast, by Disease Area

13.4.6.4. Market Revenue and Volume Forecast, by Application

13.4.7. Market Revenue and Volume Forecast, by End-User

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product Type

13.4.8.2. Market Revenue and Volume Forecast, by Technology Type

13.4.8.3. Market Revenue and Volume Forecast, by Disease Area

13.4.8.4. Market Revenue and Volume Forecast, by Application

13.4.9. Market Revenue and Volume Forecast, by End-User

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product Type

13.4.10.2. Market Revenue and Volume Forecast, by Technology Type

13.4.10.3. Market Revenue and Volume Forecast, by Disease Area

13.4.10.4. Market Revenue and Volume Forecast, by Application

13.4.10.5. Market Revenue and Volume Forecast, by End-User

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product Type

13.4.11.2. Market Revenue and Volume Forecast, by Technology Type

13.4.11.3. Market Revenue and Volume Forecast, by Disease Area

13.4.11.4. Market Revenue and Volume Forecast, by Application

13.4.11.5. Market Revenue and Volume Forecast, by End-User

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product Type

13.5.2. Market Revenue and Volume Forecast, by Technology Type

13.5.3. Market Revenue and Volume Forecast, by Disease Area

13.5.4. Market Revenue and Volume Forecast, by Application

13.5.5. Market Revenue and Volume Forecast, by End-User

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product Type

13.5.6.2. Market Revenue and Volume Forecast, by Technology Type

13.5.6.3. Market Revenue and Volume Forecast, by Disease Area

13.5.6.4. Market Revenue and Volume Forecast, by Application

13.5.7. Market Revenue and Volume Forecast, by End-User

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product Type

13.5.8.2. Market Revenue and Volume Forecast, by Technology Type

13.5.8.3. Market Revenue and Volume Forecast, by Disease Area

13.5.8.4. Market Revenue and Volume Forecast, by Application

13.5.8.5. Market Revenue and Volume Forecast, by End-User

Chapter 14. Company Profiles

14.1. Agilent Technologies

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Danaher Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Illumina, Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. PerkinElmer, Inc

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Siemens Healthineers

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. TIB Molbiol

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Takara Bio Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Bio-Techne Corporation

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. LGC Limited

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. QIAGEN N.V.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The PCR technologies market size is expected to increase from USD 15.78 billion in 2024 to USD 31.39 billion by 2034.

The PCR technologies market is expected to grow at a compound annual growth rate (CAGR) of around 7.12% from 2025 to 2034.

The major players in the PCR technologies market include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche AG, GE Healthcare (now Cytiva), Hologic, Inc., Illumina, Inc., Merck KGaA (MilliporeSigma), Myriad Genetics, PerkinElmer, Inc., QIAGEN N.V., Qiagen Digital Insights, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific, TIB Molbiol, Takara Bio Inc., Bio-Techne Corporation, and LGC Limited

The driving factors of the PCR technologies market are the innovations in real-time and digital PCR technology continue to drive growth through improvements in sensitivity, speed, and automation, thereby increasing the number of applicable settings

North America region will lead the global PCR technologies market during the forecast period 2025 to 2034.